Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
about
Meta-Analysis: Effects of Probiotic Supplementation on Lipid Profiles in Normal to Mildly Hypercholesterolemic IndividualsDietary habits and behaviors associated with nonalcoholic fatty liver diseaseUnmet need in the hyperlipidaemia population with high risk of cardiovascular disease: a targeted literature review of observational studiesShort telomere length is associated with renal impairment in Japanese subjects with cardiovascular riskPrevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in JapanEffect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients.Effect of Collagen Tripeptide on Atherosclerosis in Healthy HumansDetermination of Fasting and Non-Fasting Cholesterol Levels of Low- and High-Density Lipoproteins with Homogenous Assays: A Promising Reliable Way to Assessment of Dyslipidemia.Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting StatePlasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitusSerum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama StudyPlasma brain-derived neurotrophic factor and reverse dipping pattern of nocturnal blood pressure in patients with cardiovascular risk factors.Importance of fatty acid compositions in patients with peripheral arterial disease.Blood pressure, low-density lipoprotein cholesterol, and incidences of coronary artery disease and ischemic stroke in Japanese: the Suita studyCross-sectional study of patients with onset of acute coronary syndrome during statin therapyPredictive power of a body shape index for development of diabetes, hypertension, and dyslipidemia in Japanese adults: a retrospective cohort study.Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial.Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk FactorsLean body mass index prognostic value for cardiovascular events in patients with coronary artery disease.Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health StudyEffect of high-potency statins on HbA1c in patients with or without diabetes mellitus.Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow-Up.Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort StudiesImpaired blood rheology is associated with endothelial dysfunction in patients with coronary risk factors.Relationship Between Alcohol Drinking Pattern and Risk of Proteinuria: The Kansai Healthcare Study.Safety of atorvastatin in Asian patients within clinical trials.Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA)Pulse Pressure and Upstroke Time Are Useful Parameters for the Diagnosis of Peripheral Artery Disease in Patients With Normal Ankle Brachial Index.Postprandial Hyperlipidemia and Remnant Lipoproteins.Serum Macro TSH Level is Associated with Sleep Quality in Patients with Cardiovascular Risks - HSCAA Study.Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan.Coronary Artery Calcium and Carotid Artery Intima Media Thickness and Plaque: Clinical Use in Need of Clarification.Lipid Management in a Japanese Community:Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012.Demystifying the management of hypertriglyceridaemia.Serum lipids and prevention of atherosclerotic cardiovascular events in hemodialysis patients.Cardiovascular risk assessment: a global perspective.Patterns of statin non-prescription in patients with established coronary artery disease: A report from a contemporary multicenter Japanese PCI registryAsymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function.
P2860
Q26782512-C954CBE2-7484-46D8-B465-C5C003A77198Q26830594-B000547B-0C5D-4EEB-9A61-1654B96355A2Q28072161-8F67E9AA-95C5-4535-98C2-505BAED95A9BQ33602756-6ED8E30D-CE84-487F-BFA3-BD66ED0CE5D9Q33610981-5344254D-15E7-43D1-B0E7-3C5CAE4D20CBQ33655267-01DB355C-EE24-4E15-953C-1C7092C53871Q33676014-4D6ECF82-745A-450D-B703-EF1EECEAC4F2Q33752261-4F437C0C-CFC0-4060-8ADA-C29ADD8D9EBFQ33752270-55DE70E7-3E58-46BD-888F-95D67851E293Q33854234-288EAD25-B98F-4ACF-B891-1135A4FC25A3Q33918753-A3F1BB11-142A-4EBA-88D4-51AACDEE6344Q34083983-1D7E00AD-4A01-419F-A0DB-C9D781D3658DQ34142519-10AABB69-CCE6-4014-85FB-CC716BF19D2DQ34683708-F8D875B9-80C8-41C0-B0B3-81458BC8D596Q35166857-8DD573C3-B4B7-458C-BBE4-EA36F504F6E3Q35647686-824566B8-498A-4E1F-A9B8-5A23A1C4DFB8Q35785956-17EA3A97-1469-4191-AE6F-41EB42ED1B57Q35916476-9A6B1486-BF82-48A1-AE69-327657F40F32Q36014109-C93F7D07-B507-4FD4-A6DE-FE5DBED70AADQ36025033-D73F9A38-E4F0-4B41-8D7B-4D63D430A8A4Q36082732-8E082C13-8546-45BA-A22C-41918ABFBBDEQ36705400-C9415E94-C609-4014-B313-54C44BA1AFF2Q37000684-4C876DB8-8151-4191-8F19-4C04332159D2Q37041899-5B181BCF-13EF-49D2-A659-1776FDA3235DQ37053935-23E89986-1C18-4236-8793-C0013E42ED75Q37227104-AC706B0B-ECE2-4BA2-8D54-4A21CF9B7CE8Q37456623-231B62AD-A61C-4E02-A6F6-B210918A4C6AQ37615904-BE80BF0A-FE37-48C9-B94E-C7BE3D2384D7Q37629258-75BE6FAF-08BB-47E8-9D05-550B17C6FF53Q37639159-6BA4DA8C-B68E-4AB6-B9C2-C2DA68F0CFCAQ37695179-1EE3CB8A-1237-4B31-BB98-37462A8ED63BQ37700213-DFE43935-8D1A-47FF-AF64-AF8111C82661Q37740344-1AAF844A-8986-46D1-8370-3845F068C5AFQ37740364-82781059-2B5B-42A5-8324-C7CE800009CAQ38141575-43072F2D-CCB3-4A7D-A8D2-0BD2317CA46EQ38144931-64D208AF-D1B7-4B2B-B2FE-3DE33B461564Q38371309-B54A7ACB-55F3-4A17-9CCD-B673F49FFB39Q38640919-BEE65CD9-EFA8-4890-B7DF-F0AC41C303A5Q38732241-050792DB-B098-447F-BE92-F3E36AAFDED4Q38912914-18AC3929-187A-4222-A811-C1C81A515E1A
P2860
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Executive summary of the Japan ...... seases in Japan -2012 version.
@ast
Executive summary of the Japan ...... seases in Japan -2012 version.
@en
Executive summary of the Japan Atherosclerosis Society
@nl
type
label
Executive summary of the Japan ...... seases in Japan -2012 version.
@ast
Executive summary of the Japan ...... seases in Japan -2012 version.
@en
Executive summary of the Japan Atherosclerosis Society
@nl
prefLabel
Executive summary of the Japan ...... seases in Japan -2012 version.
@ast
Executive summary of the Japan ...... seases in Japan -2012 version.
@en
Executive summary of the Japan Atherosclerosis Society
@nl
P2093
P356
P1476
Executive summary of the Japan ...... seases in Japan -2012 version.
@en
P2093
Chizuko Maruyama
Genshi Egusa
Hiroyuki Daida
Japan Atherosclerosis Society
Jun Sasaki
Kazuhiko Hirobe
Koutaro Yokote
Makoto Kinoshita
Masayuki Yokode
P304
P356
10.5551/JAT.15792
P577
2013-05-11T00:00:00Z